Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pregnancy termination.

M Bygdeman1, K Gemzell Danielsson, L Marions

  • 1Department of Woman and Child Health, Div. for Obstetrics and Gynecology, Karolinska Hospital, S-171 76, Stockholm, Sweden. astblad@obgyn.ks.se

Steroids
|December 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of levonorgestrel emergency contraception on implantation and fertility: A review.

Contraception·2022
Same author

Management of pain associated with up-to-9-weeks medical termination of pregnancy (MToP) using mifepristone-misoprostol regimens: expert consensus based on a systematic literature review.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2019
Same author

Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Response to "study of contraceptive mobile app fails to provide convincing findings".

Contraception·2018
Same author

Clarifications concerning contraceptive mobile app Pearl Index calculations.

Contraception·2018
Same author

Fertility awareness-based mobile application.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2018
Same journal

Emerging trends for therapeutic valuation of Cyclopamine: Structural features, mechanism of action, and formulation strategies.

Steroids·2026
Same journal

The antiproliferative and antimigratory properties of the 3-biotin-B-norcholesteryl benzimidazole derivative in MCF-7 cells are mediated through G1 phase arrest and apoptosis.

Steroids·2026
Same journal

Development and validation of an LC-MS method for quantification of sex steroid hormones in skeletal muscle.

Steroids·2026
Same journal

Circulating 4β-hydroxycholesterol as a biomarker of CYP3A4 activity: beyond drug development.

Steroids·2026
Same journal

Impact of glycosylation position on flavonoid isomers' inhibition of breast cancer-associated enzyme CYP1B1.

Steroids·2026
Same journal

Synthesis NMR characterization and X-ray structure of α,β-unsaturated steroid spiroketal lactones. evaluation of cytotoxicity and anti-inflammatory activity.

Steroids·2026
See all related articles

Mifepristone combined with prostaglandins effectively terminates early and second-trimester pregnancies. This medical abortion regimen is safe, effective, and comparable to surgical methods, offering women an acceptable choice.

Area of Science:

  • Reproductive Medicine
  • Pharmacology

Background:

  • Mifepristone, an antiprogestin, induces uterine contractions and cervical ripening.
  • Its efficacy for pregnancy termination is enhanced when combined with prostaglandins.

Purpose of the Study:

  • To evaluate the efficacy and safety of mifepristone combined with prostaglandins for pregnancy termination.
  • To compare this combined treatment with surgical abortion methods.

Main Methods:

  • Administering mifepristone followed by gemeprost or misoprostol for early and second-trimester pregnancy termination.
  • Comparing outcomes with vacuum aspiration for early pregnancy termination.

Main Results:

  • Combined mifepristone and prostaglandin therapy is effective for early and second-trimester pregnancy termination.

Related Experiment Videos

  • The regimen is as effective and safe as vacuum aspiration in early pregnancy and equally acceptable to women.
  • In the second trimester, it reduces labor duration, prostaglandin dosage, and side effects.

    • Conclusions:

    • Mifepristone-prostaglandin combination is a safe and effective method for medical pregnancy termination.
    • This medical approach provides a viable alternative to surgical procedures, with significant benefits in the second trimester.